You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  1. CORPORATE - 21-07-2020

    COVID-19. Kedrion partners with Columbia University Irving MC

    Kedrion and Columbia University release video statements

    read more 
  2. EVENTS - 11-07-2020

    ISTH, Kedrion supports symposium on the importance of inhibitor eradication

    The central theme of the round table will be the optimization of the treatment of patients with Hemophilia A

    read more 
  3. EVENTS - 25-06-2020

    Kedrion supports the World Federation Of Hemophilia Virtual Summit 2020

    The company reaffirms its commitment to the patient community during the COVID-19 epidemic

    read more 
  4. CORPORATE - 22-06-2020

    Kedrion-Kamada collaboration, first batch of Covid-19 IG released in Israel

    The two companies are now working to expand the Clinical Development Program to the US

    read more 

Pages

For more information please contact: pressoffice@kedrion.com